Latest Breaking News On - Guido zaman - Page 1 : comparemela.com

Super-Glue Molecule Promises New Cancer Drug Discovery

Super-Glue Molecule Promises New Cancer Drug Discovery
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Kaiwen yuMarcus fischerKristin richingDarcie millerAnand mayasundariSarah youngJunmin pengJeffery klcoRyan hiltenbrandAnang shelatAnup aggarwalXusheng wangYunchao changSherif abdelhamedDanette danielsGisele nishiguchi

Molecular Super-Glue Promises New Cancer Drug Discovery

Molecular Super-Glue Promises New Cancer Drug Discovery
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Jeffrey kooijmanAnand mayasundariRavi kalathurKaiwen yuCharles mullighanElizabeth caineDanette danielsXusheng wangSherif abdelhamedJeffery klcoAnang shelatRyan hiltenbrandShondra pruett millerGuido zamanMarcus fischerSuiping zhou

Molecular super-glue shows promise of cancer drug discovery platform

Molecular super-glue shows promise of cancer drug discovery platform
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.

Anand mayasundariAnup aggarwalSourav dasLauren mascibrodaJunmin pengKevin mcgowanDarcie millerCharles mullighanGuido zamanGisele nishiguchiZoran rankovicChelsea bryantSuiping zhouKaiwen yuYunchao changJeffrey kooijman

Molecular super-glue shows promise of cancer drug discovery platform

Junmin pengDarcie millerKevin mcgowanAnup aggarwalAnand mayasundariLauren mascibrodaSourav dasGisele nishiguchiCharles mullighanGuido zamanSuiping zhouZoran rankovicChelsea bryantYunchao changJeffrey kooijmanJuan barajas

Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities

Symeres, a leading global drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), today announces the acquisition of Oncolines, a Netherlands-based CRO that provides early biology services and cell-line profiling assays. Oncolines is Symeres’ third .

United statesGuido zamanEelco ebbersContract developmentContract research organizationSymeres groupManufacturing organizationEuropean growth buyoutManaging directorNorth america